MARC at Georgia State University: Workforce Diversity through Honors Undergraduates
MARC at Georgia State University: Workforce Diversity through Honors Undergraduates
批准号:
10166878
负责人:
Ritu Aneja
金额:
$35.06万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-06-01 至 2024-05-31
关键词:
AssistantshipAwarenessBachelor&aposs DegreeBehavioral SciencesBenchmarkingBiologyBiotechnologyCCL7 geneCareer ChoiceChemistryCommunicationDevelopmentDiseaseDoctor of PhilosophyEducationEducational workshopEnvironmentEvaluationExposure toFacultyFoundationsFundingIndividualInosine DiphosphateInstitutesInstitutionIonsLeadLifeMeasuresMentorsMinorityMolecularNeurosciencesPersonsPopulationPositioning AttributePrincipal InvestigatorPsychologyResearchScienceSelf EfficacyStudentsTechnical ExpertiseTimeTimeLineTrainingTravelUnderrepresented PopulationsUnited States National Institutes of HealthUniversitiesbasebrain behaviorcareercohortcollegeexternshipfield triphigh school programprogramspsychosocialrecruitskillssymposiumtraining opportunityundergraduate research experienceundergraduate student
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT ABSTRACT
MARC at Georgia State University (MARC@GSU) will create workforce diversity through honors
undergraduates. GSU is the “right place at the right time” for a new MARC program; our institution offers an
unusual combination of “research intensive institution” with over 50,000 students in a “minority-majority”
population. Yet the institutional culture does not yet support impressive levels of alumni earning PhDs. A
strategic thrust of MARC@GSU will be to leverage GSU’s growing number of state-of-the-art interdisciplinary
undergraduate programs like B&B (Brains & Behavior), MBD (Molecular Basis of Disease), and IMSD
(Initiative for Maximizing Student Development), as well as summer high-school programs like CTY (Catch
Them Young) and ION (Institute on Neuroscience), to provide hands-on training, opportunities to cultivate life
and professional skills, and gain in-person exposure to career pathways in biomedical and behavioral
sciences. MARC will help us reach critical mass of support programs and training funds to change our culture.
Out of almost 1,000 MARC-eligible undergraduates in biology, chemistry, neuroscience, and psychology, we
will recruit 6-8 per cohort into our wrap-around programming grounded in four program objectives: 1) engage
students in state-of-the-art research assistantships at GSU and externships at Harvard or Vanderbilt; 2)
enhance the academic environment through honors-level course-based undergraduate research experiences
(CUREs), seminars, a futuristic biotechnology course, and honors theses; 3) promote scientific communication,
psychosocial awareness, and technical skills through workshops, conference travel, maker projects, and
professional stewardship; and 4) maximize comprehensive mentoring and individualized career support
through NRMN mentor training. IDPs, professional field trips, and timeline planning apps will alert scholars to a
diverse array of career paths in research and facilitate clear career planning. Per our evaluation plan, we will
evaluate student progress toward internal dispositions that predict research careers (e.g. self-efficacy and
science identity), and measure the NIH benchmarks of 90% of MARC Scholars completing bachelor’s degrees,
60% proceeding into PhD programs, and 80% of those completing their advanced degrees. A balanced pair of
Co-Principal Investigators, with expertise in both education and bench science, is well-positioned to lead a
diverse and enthusiastic team of four key faculty, and over 30 supportive and productive faculty preceptors,
working with foundational support from the Honors College and a new Center for the Advancement of Students
and Alumni (CASA) at Georgia State. Ultimately, MARC@GSU will prepare individuals from underrepresented
groups for successful research careers, thereby helping to enhance the US research workforce.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MARC Supplement at Georgia State University: Workforce Diversity Through Enhanced Mentoring
-
批准号:10394018
-
项目类别:
-
资助金额:$6.67万
-
财政年份:2019
-
负责人:Ritu Aneja
-
依托单位:
HSET as a racial disparity biomarker for TNBC patients
-
批准号:9898334
-
项目类别:
-
资助金额:$76.35万
-
财政年份:2019
-
负责人:Ritu Aneja
-
依托单位:
HSET as a racial disparity biomarker for TNBC patients
-
批准号:10632100
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Ritu Aneja
-
依托单位:
HSET as a racial disparity biomarker for TNBC patients
-
批准号:10619237
-
项目类别:
-
资助金额:$55.13万
-
财政年份:2019
-
负责人:Ritu Aneja
-
依托单位:
UAB Cancer Prevention and Control Training Program (T32)
-
批准号:10427303
-
项目类别:
-
资助金额:$44.4万
-
财政年份:2018
-
负责人:Ritu Aneja
-
依托单位:
Evaluation of centrosome amplification as a risk-predictor for breast cancer aggr
-
批准号:8968791
-
项目类别:
-
资助金额:$4.77万
-
财政年份:2015
-
负责人:Ritu Aneja
-
依托单位:
A novel racial disparity marker for risk prediction in triple negative breast cancer patients
-
批准号:8997736
-
项目类别:
-
资助金额:$20.75万
-
财政年份:2015
-
负责人:Ritu Aneja
-
依托单位:
Enhancing prognostic power of tumor grade by revisiting Ki67-mitosis relationship
-
批准号:8895609
-
项目类别:
-
资助金额:$7.4万
-
财政年份:2015
-
负责人:Ritu Aneja
-
依托单位:
Evaluation of centrosome amplification as a risk-predictor for breast cancer aggr
-
批准号:9149174
-
项目类别:
-
资助金额:$30.71万
-
财政年份:2014
-
负责人:Ritu Aneja
-
依托单位:
Evaluation of centrosome amplification as a risk-predictor for breast cancer aggr
-
批准号:8930931
-
项目类别:
-
资助金额:$30.71万
-
财政年份:2014
-
负责人:Ritu Aneja
-
依托单位:
Evaluation of centrosome amplification as a risk-predictor for breast cancer aggr
-
批准号:9339617
-
项目类别:
-
资助金额:$30.32万
-
财政年份:2014
-
负责人:Ritu Aneja
-
依托单位:
Evaluation of centrosome amplification as a risk-predictor for breast cancer aggr
-
批准号:8774495
-
项目类别:
-
资助金额:$30.71万
-
财政年份:2014
-
负责人:Ritu Aneja
-
依托单位:
Evaluation of HSET as a Novel Theranostic Target for Breast Cancer Therapy
-
批准号:8518273
-
项目类别:
-
资助金额:$28.18万
-
财政年份:2012
-
负责人:Ritu Aneja
-
依托单位:
Evaluation of HSET as a Novel Theranostic Target for Breast Cancer Therapy
-
批准号:9320098
-
项目类别:
-
资助金额:$4.56万
-
财政年份:2012
-
负责人:Ritu Aneja
-
依托单位:
Evaluation of HSET as a Novel Theranostic Target for Breast Cancer Therapy
-
批准号:9086291
-
项目类别:
-
资助金额:$29.98万
-
财政年份:2012
-
负责人:Ritu Aneja
-
依托单位:
Evaluation of HSET as a Novel Theranostic Target for Breast Cancer Therapy
-
批准号:8676746
-
项目类别:
-
资助金额:$29.08万
-
财政年份:2012
-
负责人:Ritu Aneja
-
依托单位:
Evaluation of HSET as a Novel Theranostic Target for Breast Cancer Therapy
-
批准号:9064260
-
项目类别:
-
资助金额:$4.81万
-
财政年份:2012
-
负责人:Ritu Aneja
-
依托单位:
Evaluation of HSET as a Novel Theranostic Target for Breast Cancer Therapy
-
批准号:8839353
-
项目类别:
-
资助金额:$4.67万
-
财政年份:2012
-
负责人:Ritu Aneja
-
依托单位:
Evaluation of HSET as a Novel Theranostic Target for Breast Cancer Therapy
-
批准号:8345799
-
项目类别:
-
资助金额:$29.98万
-
财政年份:2012
-
负责人:Ritu Aneja
-
依托单位:
Evaluation of HSET as a Novel Theranostic Target for Breast Cancer Therapy
-
批准号:8656663
-
项目类别:
-
资助金额:$4.11万
-
财政年份:2012
-
负责人:Ritu Aneja
-
依托单位:
海外基金